Briefs: Marksans Pharma and Alkem
News

Briefs: Marksans Pharma and Alkem

The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.

  • By IPP Bureau | June 22, 2022

Marksans Pharma recalls Kroger brand Aspirin and Ibuprofen

Marksans Pharma Limited's (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) wholly owned subsidiary Time-Cap Laboratories Inc. recalls Kroger Brand Aspirin (300 count bottles) and Ibuprofen (160 count bottles) due to label packaging issue to meet child resistant packaging requirement. Total 12 lots containing 209,430 units have been recalled.

US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA

The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA from 06th June, 2022 to 17th June, 2022.

At the end of the inspection, the Company has received Form 483 with three (3) observations. The Company shall submit to US FDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection.

Upcoming E-conference

Other Related stories

Startup

Digitization